Effects of manipulation of N-methyl-D-aspartate receptors on imipenem/cilastatin-induced seizures in rats

Indian Journal of Medical Research

Volumn 119, Issue 2, 2004, Pages 79-85

  Zivanovic, Dragana ^a   Stanojlovic, Olivera ^a   Susic, Veselinka ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

APV; EEG; HA 966; Imipenem cilastatin; NMDA; Remacemide; Seizures

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 3 AMINO 1 HYDROXY 2 PYRROLIDINONE; CILASTATIN PLUS IMIPENEM; GLYCINE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; REMACEMIDE; SODIUM CHLORIDE; THIENAM;

AMPLITUDE MODULATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CANNULATION; COMPLEX FORMATION; CONTROLLED STUDY; CONVULSION; DEATH; DISEASE SEVERITY; DOSE RESPONSE; ELECTRODE; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; FREQUENCY MODULATION; INCIDENCE; LATENT PERIOD; LATERAL BRAIN VENTRICLE; LETHALITY; MALE; NERVOUS SYSTEM PARAMETERS; NEUROTRANSMISSION; NONHUMAN; OUTCOMES RESEARCH; RAT; RAT STRAIN; SEIZURE; SPIKE; STATISTICAL SIGNIFICANCE; TIME; TONIC CLONIC SEIZURE;

ACETAMIDES; ANIMALS; BINDING SITES; CILASTATIN; ELECTROENCEPHALOGRAPHY; IMIPENEM; MALE; PYRROLIDINONES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; VALINE;

EID: 1542502973     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Meldrum BS, Croucher MJ, Czuczwar SJ, Collins JF, Curry K, Joseph M, et al. A comparison of the anticonvulsant potency of (±)2-amino-5-phosphonopentanoic acid and (±)2-amino-7-phosphonoheptanoic acid. Neuroscience 1983; 9 : 925-30.
2. Koek W, Colpaert FC. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonist and putative glycine antagonists: Relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 1990; 252 : 349-57.
3. Czuczwar SJ, Frey HH, Loscher W. Antagonism of N-methyl-D, L-aspartic acid-induced convulsions by antiepileptic drugs and other agents. Eur J Pharmacol 1985; 108 : 273-80.
4. Loeb C, Patrone A, Besio G, Balestrino M, Mainardi P. The excitatory amino acid antagonist amino-phosphono-valeric acid (APV) provides protection against penicillin-induced epileptic activity in the rat. Epilepsy Res 1990; 6 : 249-51.
5. Croucher MJ, Cotterell KL, Bradford HF. Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds. Neurochem Res 1992; 17 : 409-13.
6. Croucher MJ, Collins JF, Meldrum BS. Anticonvulsant action of excitatory amino acid antagonists. Science 1982; 216 : 899-901.
7. Debler EA, Lipovac MN, Lajtha A, Zlokovic BV, Dunlop DS, Jacobson AE, et al. Metaphit-induced audiogenic seizures in mice: I. Pharmacologic characterization. Epilepsia 1993; 34 : 201-10.
8. Zivanovic D, Susic V, Stanojlovic O. Inhibition of metaphit-induced audiogenic seizures by APV in rats. Physiol Res 1999; 48 : 149-56.
9. Stagnitto ML, Palmer GC, Ordy JM, Griffith RC, Napier JJ, Becker CN, et al. Preclinical profile of remacemide: A novel anticonvulsant effective against maximal electroshock seizures in mice. Epilepsy Res 1990; 7 : 11-28.
10. Davies JA. Remacemide hydrochloride: A novel antiepileptic agent. Gen Pharmacol 1997; 28: 499-502.
11. Van Luijtelaar ELJM, Coenen AML. Effects of remacemide and its metabolite FPL 12495 on spike-wave discharges, electroencephalogram and behaviour in rats with absence epilepsy. Neuropharmacology 1995; 34 : 419-25.
12. Chiamulera C, Costa S, Reggiani A. Effect of NMDA - and strychnine-insensitive glycine site antagonists on NMDA - mediated convulsions and learning. Psychopharmacology (Berl) 1990; 102 : 551-2.
13. Rundfeldt C, Wlaz P, Loscher W. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy. Brain Res 1994; 653 : 125-30.
14. Singh L, Donald AE, Foster AC, Hutson PH, Iversen LL, Iversen SD, et al. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist but (-)-HA-966 is a potent γ-butyrolactone-like sedative. Proc Natl Acad Sci USA 1990; 87 : 347-51.
15. Barza M. Imipenem: First of a new class of beta-lactam antibiotics. Ann Intern Med 1985; 103 : 552-60.
16. Leo RJ, Ballow CH. Seizure activity associated with imipenem use: Clinical case reports and review of the literature. DICP 1991; 25 : 351-4.
17. De Sarro A, Imperatore C, Mastroeni P, De Sarro G. Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice. J Pharm Pharmacol 1995; 47 : 292-6.
18. de Sarro G, Ammendola D, Nava F, De Sarro A. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice. Brain Res 1995; 671 : 131-40.
19. Kamei C, Kitazumi K, Tsujimoto S, Yoshida T, Tasaka K. Comparative study of certain antibiotics on epileptogenic property, including (1Rpi, 5S, 6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)] thio-6-[(R)-1-hydroxyethyl]-1-methyl-carbapenem-3-carboxylate (LJC10627), a carbapenem antibiotic with broad antimicrobial spectrum. J Pharmacobio-Dyn 1991; 14 : 509-17.
20. A, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats. Antimicrob Agents Chemother 1993; 37 : 199-202.
21. Williams PD, Bennett DB, Comerski CR. Animal model for evaluating the convulsive liability of β-lactam antibiotics. Antimicrob Agents Chemother 1988; 32 : 758-60.
22. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. London: Academic Press; 1982.
23. Cain DP, Desborough KA, McItrick DJ. Retardation of amygdala kindling by antagonism of NMD-aspartate and muscarinic cholinergic receptors: Evidence for the summation of excitatory mechanisms in kindling. Exp Neurol 1988; 100 : 179-87.
24. Klockgether T, Turski L, Schwarz M, Sontag KH, Lehmann J. Paradoxical convulsant action of a novel non-competitive N-methyl-D-aspartate (NMDA) antagonist, tiletamine. Brain Res 1988; 461 : 343-8.
25. Owen L, Cresswell P, Gifford C, McDade G, Mawer G. Influence of remacemide on EEG in chronic epilepsy. Epilepsy Res 1992; 1 (Suppl A) 7.
26. Garske GE, Palmer GC, Napier JJ, Griffith RC, Freedman LR, Harish EW, et al. Preclinical profile of the anticonvulsant remacemide and its enantiomers in the rat. Epilepsy Res 1991; 9 : 161-74.